Org.nr 915 108 598 2020 → 2021 Year-over-year analysis

ABLY MEDICAL AS: årsregnskap 2021 vs 2020

Grew 26% on revenue, weaker earnings, fresh owner capital

approved 2022-06-07; registry 2022-06-23; journal 2022 492878

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2021 with 2020 for ABLY MEDICAL AS. Revenue 13.34m NOK → 16.80m NOK (+25.9%). Net result -7.24m NOK → -21.94m NOK. Equity 18.71m NOK → 37.86m NOK.

On the constructive side: revenue rose; equity strengthened; cash rose. Pressures included: operating result weakened; net result weakened.

Also worth watching: headcount (årsverk) changed. All figures are taken from the published annual accounts for ABLY MEDICAL AS.

Scorecard

Revenue
13.34m NOK 16.80m NOK
+25.9%
Operating result
-6.76m NOK -21.60m NOK
-219.4%
Net result
-7.24m NOK -21.94m NOK
-203.1%
Equity
18.71m NOK 37.86m NOK
+102.3%
Cash
4.28m NOK 22.27m NOK
+420.1%
Total assets
31.64m NOK 50.72m NOK
+60.3%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 13.34m NOK to 16.80m NOK (+25.9% YoY). Calculated

  • ↑

    Equity strengthened

    Book equity 18.71m NOK → 37.86m NOK (equity ratio 59.2% → 74.7%). Calculated

  • ↑

    Cash rose

    Bank deposits 4.28m NOK → 22.27m NOK (+420.1% YoY). Calculated

  • ↑

    Current ratio back above 1×

    Current ratio 0.54× → 3.68×. Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 18.71m NOK → 37.86m NOK (+19.15m NOK). Reported fact

What deteriorated

  • ↓

    Operating result weakened

    Operating result -6.76m NOK → -21.60m NOK (op. margin -50.7% → -128.6%). Calculated

  • ↓

    Net result weakened

    Net result -7.24m NOK → -21.94m NOK (net margin -54.3% → -130.6%). Calculated

Things to notice

  • ·

    Headcount (årsverk) changed

    Reported FTEs 14 → 14.5. Reported fact